logo
Plus   Neg
Share
Email

Roche Enters Deal With Blueprint Medicines To Gain Co-development Rights For Pralsetinib

Roche (RHHBY) and Blueprint Medicines Corp. (BPMC) have signed a licensing and collaboration agreement on the development of pralsetinib providing exclusive rights to Roche for global co-development and commercialisation outside the US, excluding Greater China. In the US, Genentech, a member of the Roche Group, will obtain co-commercialisation rights to pralsetinib, Blueprint Medicine's investigational, once-daily oral precision therapy for the treatment of people with RET-altered non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer, as well as other solid tumours.

Blueprint will receive an upfront cash payment of $675 million and a $100 million equity investment in Blueprint Medicines' common stock. Blueprint is also eligible to receive up to $927 million in contingent development, regulatory and sales-based milestones, and royalties on net product sales outside the US.

Blueprint Medicines has submitted a new drug application for pralsetinib to the FDA and a marketing authorisation application to the European Medicines Agency for the treatment of RET fusion-positive non-small cell lung cancer. The FDA granted priority review with an expected decision date of 23 November 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon.com, Inc. can be held liable for damages caused by defective goods sold on its Marketplace including third parties, according to a ruling by a California appeals court. The California Fourth District Court of Appeals was pronouncing the ruling in a case where a defective replacement laptop battery caught fire and inflicted a woman with third-degree burns. Facebook has launched "Voting Information Center" on Facebook and Instagram platforms, with a view to boosting the number of Americans vote in the upcoming U.S. presidential election in November. The social media giant's latest initiative is expected to help 4 million voters register this year, and help them navigate a 'confusing election process'. Epic Games Inc., the developer of popular game Fortnite, has filed lawsuits against both Apple Inc. and Google after they removed the game from their app stores. The development reflects disputes related to app store fee the tech giants take from each purchase. Epic Games, which has been against the 30 percent revenue cut the two tech giants take from paid apps, added a direct payment option.
Follow RTT